Report Cover

Global and United States DNA Repair Drugs Market Insights, Forecast to 2027


DNA Repair Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global DNA Repair Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the DNA Repair Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
    PARP Inhibitors
    Other

Segment by Application
    Oncological
    Stroke

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E

By Company
    4SC AG
    ARCAGY/ GINECO GROUP
    Bristol Myers Squibb
    British Columbia Cancer Agency
    Cambridge University Hospitals NHS Foundation Trust
    Genentech
    Georgetown University
    German Breast Group
    GlaxoSmithKline
    Jiangsu Hengrui Medicine
    Johnson & Johnson
    Jonsson Comprehensive Cancer Center
    Karyopharm Therapeutics
    KuDOS Pharmaceuticals
    National Health Service
    National Institutes of Health
    Tesaro
1 Study Coverage
    1.1 DNA Repair Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global DNA Repair Drugs Market Size Growth Rate by Type
        1.2.2 PARP Inhibitors
        1.2.3 Other
    1.3 Market by Application
        1.3.1 Global DNA Repair Drugs Market Size Growth Rate by Application
        1.3.2 Oncological
        1.3.3 Stroke
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global DNA Repair Drugs Market Size, Estimates and Forecasts
        2.1.1 Global DNA Repair Drugs Revenue 2016-2027
        2.1.2 Global DNA Repair Drugs Sales 2016-2027
    2.2 Global DNA Repair Drugs, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 DNA Repair Drugs Historical Market Size by Region (2016-2021)
        2.3.1 Global DNA Repair Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global DNA Repair Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 DNA Repair Drugs Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global DNA Repair Drugs Sales Forecast by Region (2022-2027)
        2.4.2 Global DNA Repair Drugs Revenue Forecast by Region (2022-2027)

3 Global DNA Repair Drugs Competitor Landscape by Players
    3.1 Global Top DNA Repair Drugs Manufacturers by Sales
        3.1.1 Global DNA Repair Drugs Sales by Manufacturer (2016-2021)
        3.1.2 Global DNA Repair Drugs Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top DNA Repair Drugs Manufacturers by Revenue
        3.2.1 Key DNA Repair Drugs Manufacturers Covered: Ranking by Revenue
        3.2.2 Global DNA Repair Drugs Revenue by Manufacturers (2016-2021)
        3.2.3 Global DNA Repair Drugs Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global DNA Repair Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by DNA Repair Drugs Revenue in 2020
        3.2.6 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global DNA Repair Drugs Price by Manufacturers
    3.4 Global DNA Repair Drugs Manufacturing Base Distribution, Product Types
        3.4.1 DNA Repair Drugs Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers DNA Repair Drugs Product Type
        3.4.3 Date of International Manufacturers Enter into DNA Repair Drugs Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global DNA Repair Drugs Market Size by Type (2016-2021)
        4.1.1 Global DNA Repair Drugs Sales by Type (2016-2021)
        4.1.2 Global DNA Repair Drugs Revenue by Type (2016-2021)
        4.1.3 DNA Repair Drugs Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global DNA Repair Drugs Market Size Forecast by Type (2022-2027)
        4.2.1 Global DNA Repair Drugs Sales Forecast by Type (2022-2027)
        4.2.2 Global DNA Repair Drugs Revenue Forecast by Type (2022-2027)
        4.2.3 DNA Repair Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global DNA Repair Drugs Market Size by Application (2016-2021)
        5.1.1 Global DNA Repair Drugs Sales by Application (2016-2021)
        5.1.2 Global DNA Repair Drugs Revenue by Application (2016-2021)
        5.1.3 DNA Repair Drugs Price by Application (2016-2021)
    5.2 DNA Repair Drugs Market Size Forecast by Application (2022-2027)
        5.2.1 Global DNA Repair Drugs Sales Forecast by Application (2022-2027)
        5.2.2 Global DNA Repair Drugs Revenue Forecast by Application (2022-2027)
        5.2.3 Global DNA Repair Drugs Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
    6.1 United States DNA Repair Drugs Market Size YoY Growth 2016-2027
        6.1.1 United States DNA Repair Drugs Sales YoY Growth 2016-2027
        6.1.2 United States DNA Repair Drugs Revenue YoY Growth 2016-2027
        6.1.3 United States DNA Repair Drugs Market Share in Global Market 2016-2027
    6.2 United States DNA Repair Drugs Market Size by Players (International and Local Players)
        6.2.1 United States Top DNA Repair Drugs Players by Sales (2016-2021)
        6.2.2 United States Top DNA Repair Drugs Players by Revenue (2016-2021)
    6.3 United States DNA Repair Drugs Historic Market Review by Type (2016-2021)
        6.3.1 United States DNA Repair Drugs Sales Market Share by Type (2016-2021)
        6.3.2 United States DNA Repair Drugs Revenue Market Share by Type (2016-2021)
        6.3.3 United States DNA Repair Drugs Price by Type (2016-2021)
    6.4 United States DNA Repair Drugs Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 United States DNA Repair Drugs Sales Forecast by Type (2022-2027)
        6.4.2 United States DNA Repair Drugs Revenue Forecast by Type (2022-2027)
        6.4.3 United States DNA Repair Drugs Price Forecast by Type (2022-2027)
    6.5 United States DNA Repair Drugs Historic Market Review by Application (2016-2021)
        6.5.1 United States DNA Repair Drugs Sales Market Share by Application (2016-2021)
        6.5.2 United States DNA Repair Drugs Revenue Market Share by Application (2016-2021)
        6.5.3 United States DNA Repair Drugs Price by Application (2016-2021)
    6.6 United States DNA Repair Drugs Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 United States DNA Repair Drugs Sales Forecast by Application (2022-2027)
        6.6.2 United States DNA Repair Drugs Revenue Forecast by Application (2022-2027)
        6.6.3 United States DNA Repair Drugs Price Forecast by Application (2022-2027)

7 North America
    7.1 North America DNA Repair Drugs Market Size YoY Growth 2016-2027
    7.2 North America DNA Repair Drugs Market Facts & Figures by Country
        7.2.1 North America DNA Repair Drugs Sales by Country (2016-2021)
        7.2.2 North America DNA Repair Drugs Revenue by Country (2016-2021)
        7.2.3 U.S.
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific DNA Repair Drugs Market Size YoY Growth 2016-2027
    8.2 Asia Pacific DNA Repair Drugs Market Facts & Figures by Region
        8.2.1 Asia Pacific DNA Repair Drugs Sales by Region (2016-2021)
        8.2.2 Asia Pacific DNA Repair Drugs Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia
        8.2.12 Philippines
        8.2.13 Vietnam

9 Europe
    9.1 Europe DNA Repair Drugs Market Size YoY Growth 2016-2027
    9.2 Europe DNA Repair Drugs Market Facts & Figures by Country
        9.2.1 Europe DNA Repair Drugs Sales by Country (2016-2021)
        9.2.2 Europe DNA Repair Drugs Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America DNA Repair Drugs Market Size YoY Growth 2016-2027
    10.2 Latin America DNA Repair Drugs Market Facts & Figures by Country
        10.2.1 Latin America DNA Repair Drugs Sales by Country (2016-2021)
        10.2.2 Latin America DNA Repair Drugs Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa DNA Repair Drugs Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Country
        11.2.1 Middle East and Africa DNA Repair Drugs Sales by Country (2016-2021)
        11.2.2 Middle East and Africa DNA Repair Drugs Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 4SC AG
        12.1.1 4SC AG Corporation Information
        12.1.2 4SC AG Description and Business Overview
        12.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 4SC AG DNA Repair Drugs Products Offered
        12.1.5 4SC AG Recent Development
    12.2 ARCAGY/ GINECO GROUP
        12.2.1 ARCAGY/ GINECO GROUP Corporation Information
        12.2.2 ARCAGY/ GINECO GROUP Description and Business Overview
        12.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Products Offered
        12.2.5 ARCAGY/ GINECO GROUP Recent Development
    12.3 Bristol Myers Squibb
        12.3.1 Bristol Myers Squibb Corporation Information
        12.3.2 Bristol Myers Squibb Description and Business Overview
        12.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
        12.3.5 Bristol Myers Squibb Recent Development
    12.4 British Columbia Cancer Agency
        12.4.1 British Columbia Cancer Agency Corporation Information
        12.4.2 British Columbia Cancer Agency Description and Business Overview
        12.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
        12.4.5 British Columbia Cancer Agency Recent Development
    12.5 Cambridge University Hospitals NHS Foundation Trust
        12.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
        12.5.2 Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
        12.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
        12.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
    12.6 Genentech
        12.6.1 Genentech Corporation Information
        12.6.2 Genentech Description and Business Overview
        12.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Genentech DNA Repair Drugs Products Offered
        12.6.5 Genentech Recent Development
    12.7 Georgetown University
        12.7.1 Georgetown University Corporation Information
        12.7.2 Georgetown University Description and Business Overview
        12.7.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Georgetown University DNA Repair Drugs Products Offered
        12.7.5 Georgetown University Recent Development
    12.8 German Breast Group
        12.8.1 German Breast Group Corporation Information
        12.8.2 German Breast Group Description and Business Overview
        12.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 German Breast Group DNA Repair Drugs Products Offered
        12.8.5 German Breast Group Recent Development
    12.9 GlaxoSmithKline
        12.9.1 GlaxoSmithKline Corporation Information
        12.9.2 GlaxoSmithKline Description and Business Overview
        12.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
        12.9.5 GlaxoSmithKline Recent Development
    12.10 Jiangsu Hengrui Medicine
        12.10.1 Jiangsu Hengrui Medicine Corporation Information
        12.10.2 Jiangsu Hengrui Medicine Description and Business Overview
        12.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Products Offered
        12.10.5 Jiangsu Hengrui Medicine Recent Development
    12.11 4SC AG
        12.11.1 4SC AG Corporation Information
        12.11.2 4SC AG Description and Business Overview
        12.11.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 4SC AG DNA Repair Drugs Products Offered
        12.11.5 4SC AG Recent Development
    12.12 Jonsson Comprehensive Cancer Center
        12.12.1 Jonsson Comprehensive Cancer Center Corporation Information
        12.12.2 Jonsson Comprehensive Cancer Center Description and Business Overview
        12.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Jonsson Comprehensive Cancer Center Products Offered
        12.12.5 Jonsson Comprehensive Cancer Center Recent Development
    12.13 Karyopharm Therapeutics
        12.13.1 Karyopharm Therapeutics Corporation Information
        12.13.2 Karyopharm Therapeutics Description and Business Overview
        12.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Karyopharm Therapeutics Products Offered
        12.13.5 Karyopharm Therapeutics Recent Development
    12.14 KuDOS Pharmaceuticals
        12.14.1 KuDOS Pharmaceuticals Corporation Information
        12.14.2 KuDOS Pharmaceuticals Description and Business Overview
        12.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 KuDOS Pharmaceuticals Products Offered
        12.14.5 KuDOS Pharmaceuticals Recent Development
    12.15 National Health Service
        12.15.1 National Health Service Corporation Information
        12.15.2 National Health Service Description and Business Overview
        12.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.15.4 National Health Service Products Offered
        12.15.5 National Health Service Recent Development
    12.16 National Institutes of Health
        12.16.1 National Institutes of Health Corporation Information
        12.16.2 National Institutes of Health Description and Business Overview
        12.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.16.4 National Institutes of Health Products Offered
        12.16.5 National Institutes of Health Recent Development
    12.17 Tesaro
        12.17.1 Tesaro Corporation Information
        12.17.2 Tesaro Description and Business Overview
        12.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.17.4 Tesaro Products Offered
        12.17.5 Tesaro Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 DNA Repair Drugs Industry Trends
    13.2 DNA Repair Drugs Market Drivers
    13.3 DNA Repair Drugs Market Challenges
    13.4 DNA Repair Drugs Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 DNA Repair Drugs Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Global DNA Repair Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of PARP Inhibitors Table 3. Major Manufacturers of Other Table 4. Global DNA Repair Drugs Market Size Growth Rate by Application (2021-2027) & (K Units) Table 5. Global DNA Repair Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global DNA Repair Drugs Sales by Regions (2016-2021) & (K Units) Table 7. Global DNA Repair Drugs Sales Market Share by Regions (2016-2021) Table 8. Global DNA Repair Drugs Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global DNA Repair Drugs Sales Forecast by Region (2022-2027) & (K Units) Table 10. Global DNA Repair Drugs Sales Market Share Forecast by Region (2022-2027) Table 11. Global DNA Repair Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global DNA Repair Drugs Revenue Market Share Forecast by Region (2022-2027) Table 13. Global DNA Repair Drugs Sales by Manufacturers (2016-2021) (K Units) Table 14. Global DNA Repair Drugs Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top DNA Repair Drugs Manufacturers by Revenue (US$ Million) in 2020 Table 16. DNA Repair Drugs Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. DNA Repair Drugs Revenue Share by Manufacturers (2016-2021) Table 18. Global DNA Repair Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global DNA Repair Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Repair Drugs as of 2020) Table 20. Key Manufacturers DNA Repair Drugs Price (2016-2021) (USD/Unit) Table 21. DNA Repair Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers DNA Repair Drugs Product Type Table 23. Date of International Manufacturers Enter into DNA Repair Drugs Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global DNA Repair Drugs Sales by Type (2016-2021) (K Units) Table 26. Global DNA Repair Drugs Sales Share by Type (2016-2021) Table 27. Global DNA Repair Drugs Revenue by Type (2016-2021) (US$ Million) Table 28. Global DNA Repair Drugs Revenue Share by Type (2016-2021) Table 29. DNA Repair Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Table 30. Global DNA Repair Drugs Sales Forecast by Type (2022-2027) & (K Units) Table 31. Global DNA Repair Drugs Sales Market Share Forecast by Type (2022-2027) Table 32. Global DNA Repair Drugs Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global DNA Repair Drugs Revenue Market Share Forecast by Type (2022-2027) Table 34. Global DNA Repair Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) Table 35. Global DNA Repair Drugs Sales by Application (2016-2021) (K Units) Table 36. Global DNA Repair Drugs Sales Share by Application (2016-2021) Table 37. Global DNA Repair Drugs Revenue by Application (2016-2021) (US$ Million) Table 38. Global DNA Repair Drugs Revenue Share by Application (2016-2021) Table 39. DNA Repair Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Table 40. Global DNA Repair Drugs Sales Forecast by Application (2022-2027) & (K Units) Table 41. Global DNA Repair Drugs Sales Market Share Forecast by Application (2022-2027) Table 42. Global DNA Repair Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global DNA Repair Drugs Revenue Market Share Forecast by Application (2022-2027) Table 44. Global DNA Repair Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit) Table 45. United States DNA Repair Drugs Sales (K Units) of Key Companies (2016-2021) Table 46. United States DNA Repair Drugs Sales Share by Company (2016-2021) Table 47. United States DNA Repair Drugs Revenue (US$ Million) by Company (2016-2021) Table 48. United States DNA Repair Drugs Revenue Share by Company (2016-2021) Table 49. United States DNA Repair Drugs Sales (K Units) by Type (2016-2021) Table 50. United States DNA Repair Drugs Sales Share by Type (2016-2021) Table 51. United States DNA Repair Drugs Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. United States DNA Repair Drugs Price (USD/Unit) by Type (2016-2021) Table 53. United States DNA Repair Drugs Sales (K Units) by Type (2022-2027) Table 54. United States DNA Repair Drugs Sales Share by Type (2022-2027) Table 55. United States DNA Repair Drugs Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. United States DNA Repair Drugs Revenue Share by Type (2022-2027) Table 57. United States DNA Repair Drugs Price (USD/Unit) by Type (2022-2027) Table 58. United States DNA Repair Drugs Sales (K Units) by Application (2016-2021) Table 59. United States DNA Repair Drugs Sales Share by Application (2016-2021) Table 60. United States DNA Repair Drugs Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. United States DNA Repair Drugs Price (USD/Unit) by Application (2016-2021) Table 62. United States DNA Repair Drugs Sales (K Units) by Application (2022-2027) Table 63. United States DNA Repair Drugs Sales Share by Application (2022-2027) Table 64. United States DNA Repair Drugs Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. United States DNA Repair Drugs Revenue Share by Application (2022-2027) Table 66. United States DNA Repair Drugs Price (USD/Unit) by Application (2022-2027) Table 67. North America DNA Repair Drugs Sales by Country (2016-2021) & (K Units) Table 68. North America DNA Repair Drugs Sales Market Share by Country (2016-2021) Table 69. North America DNA Repair Drugs Revenue by Country (2016-2021) & (US$ Million) Table 70. North America DNA Repair Drugs Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific DNA Repair Drugs Sales by Region (2016-2021) & (K Units) Table 72. Asia Pacific DNA Repair Drugs Sales Market Share by Region (2016-2021) Table 73. Asia Pacific DNA Repair Drugs Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific DNA Repair Drugs Revenue Market Share by Region (2016-2021) Table 75. Europe DNA Repair Drugs Sales by Country (2016-2021) & (K Units) Table 76. Europe DNA Repair Drugs Sales Market Share by Country (2016-2021) Table 77. Europe DNA Repair Drugs Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe DNA Repair Drugs Revenue Market Share by Country (2016-2021) Table 79. Latin America DNA Repair Drugs Sales by Country (2016-2021) & (K Units) Table 80. Latin America DNA Repair Drugs Sales Market Share by Country (2016-2021) Table 81. Latin Americaa DNA Repair Drugs Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America DNA Repair Drugs Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa DNA Repair Drugs Sales by Country (2016-2021) & (K Units) Table 84. Middle East and Africa DNA Repair Drugs Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa DNA Repair Drugs Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa DNA Repair Drugs Revenue Market Share by Country (2016-2021) Table 87. 4SC AG Corporation Information Table 88. 4SC AG Description and Business Overview Table 89. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 90. 4SC AG DNA Repair Drugs Product Table 91. 4SC AG Recent Development Table 92. ARCAGY/ GINECO GROUP Corporation Information Table 93. ARCAGY/ GINECO GROUP Description and Business Overview Table 94. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 95. ARCAGY/ GINECO GROUP Product Table 96. ARCAGY/ GINECO GROUP Recent Development Table 97. Bristol Myers Squibb Corporation Information Table 98. Bristol Myers Squibb Description and Business Overview Table 99. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 100. Bristol Myers Squibb Product Table 101. Bristol Myers Squibb Recent Development Table 102. British Columbia Cancer Agency Corporation Information Table 103. British Columbia Cancer Agency Description and Business Overview Table 104. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 105. British Columbia Cancer Agency Product Table 106. British Columbia Cancer Agency Recent Development Table 107. Cambridge University Hospitals NHS Foundation Trust Corporation Information Table 108. Cambridge University Hospitals NHS Foundation Trust Description and Business Overview Table 109. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 110. Cambridge University Hospitals NHS Foundation Trust Product Table 111. Cambridge University Hospitals NHS Foundation Trust Recent Development Table 112. Genentech Corporation Information Table 113. Genentech Description and Business Overview Table 114. Genentech DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 115. Genentech Product Table 116. Genentech Recent Development Table 117. Georgetown University Corporation Information Table 118. Georgetown University Description and Business Overview Table 119. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 120. Georgetown University Product Table 121. Georgetown University Recent Development Table 122. German Breast Group Corporation Information Table 123. German Breast Group Description and Business Overview Table 124. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 125. German Breast Group Product Table 126. German Breast Group Recent Development Table 127. GlaxoSmithKline Corporation Information Table 128. GlaxoSmithKline Description and Business Overview Table 129. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 130. GlaxoSmithKline Product Table 131. GlaxoSmithKline Recent Development Table 132. Jiangsu Hengrui Medicine Corporation Information Table 133. Jiangsu Hengrui Medicine Description and Business Overview Table 134. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 135. Jiangsu Hengrui Medicine Product Table 136. Jiangsu Hengrui Medicine Recent Development Table 137. Johnson & Johnson Corporation Information Table 138. Johnson & Johnson Description and Business Overview Table 139. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 140. Johnson & Johnson Product Table 141. Johnson & Johnson Recent Development Table 142. Jonsson Comprehensive Cancer Center Corporation Information Table 143. Jonsson Comprehensive Cancer Center Description and Business Overview Table 144. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 145. Jonsson Comprehensive Cancer Center Product Table 146. Jonsson Comprehensive Cancer Center Recent Development Table 147. Karyopharm Therapeutics Corporation Information Table 148. Karyopharm Therapeutics Description and Business Overview Table 149. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 150. Karyopharm Therapeutics Product Table 151. Karyopharm Therapeutics Recent Development Table 152. KuDOS Pharmaceuticals Corporation Information Table 153. KuDOS Pharmaceuticals Description and Business Overview Table 154. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 155. KuDOS Pharmaceuticals Product Table 156. KuDOS Pharmaceuticals Recent Development Table 157. National Health Service Corporation Information Table 158. National Health Service Description and Business Overview Table 159. National Health Service DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 160. National Health Service Product Table 161. National Health Service Recent Development Table 162. National Institutes of Health Corporation Information Table 163. National Institutes of Health Description and Business Overview Table 164. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 165. National Institutes of Health Product Table 166. National Institutes of Health Recent Development Table 167. Tesaro Corporation Information Table 168. Tesaro Description and Business Overview Table 169. Tesaro DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 170. Tesaro Product Table 171. Tesaro Recent Development Table 172. DNA Repair Drugs Market Trends Table 173. DNA Repair Drugs Market Drivers Table 174. DNA Repair Drugs Market Challenges Table 175. DNA Repair Drugs Market Restraints Table 176. DNA Repair Drugs Customers List Table 177. DNA Repair Drugs Distributors List Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. DNA Repair Drugs Product Picture Figure 2. Global DNA Repair Drugs Sales Market Share by Type in 2020 & 2027 Figure 3. PARP Inhibitors Product Picture Figure 4. Other Product Picture Figure 5. Global DNA Repair Drugs Sales Market Share by Application in 2020 & 2027 Figure 6. Oncological Figure 7. Stroke Figure 8. DNA Repair Drugs Report Years Considered Figure 9. Global DNA Repair Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global DNA Repair Drugs Market Size 2016-2027 (US$ Million) Figure 11. Global DNA Repair Drugs Sales 2016-2027 (K Units) Figure 12. Global DNA Repair Drugs Market Size Market Share by Region: 2021 Versus 2027 Figure 13. Global DNA Repair Drugs Sales Market Share by Region (2016-2021) Figure 14. Global DNA Repair Drugs Sales Market Share by Region in 2020 Figure 15. Global DNA Repair Drugs Revenue Market Share by Region (2016-2021) Figure 16. Global DNA Repair Drugs Revenue Market Share by Region in 2020 Figure 17. Global DNA Repair Drugs Sales Share by Manufacturer in 2020 Figure 18. The Top 10 and 5 Players Market Share by DNA Repair Drugs Revenue in 2020 Figure 19. DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global DNA Repair Drugs Sales Market Share by Type (2016-2021) Figure 21. Global DNA Repair Drugs Sales Market Share by Type in 2020 Figure 22. Global DNA Repair Drugs Revenue Market Share by Type (2016-2021) Figure 23. Global DNA Repair Drugs Revenue Market Share by Type in 2020 Figure 24. Global DNA Repair Drugs Sales Market Share by Application (2016-2021) Figure 25. Global DNA Repair Drugs Sales Market Share by Application in 2020 Figure 26. Global DNA Repair Drugs Revenue Market Share by Application (2016-2021) Figure 27. Global DNA Repair Drugs Revenue Market Share by Application in 2020 Figure 28. United States DNA Repair Drugs Sales Growth Rate 2016-2027 (K Units) Figure 29. United States DNA Repair Drugs Revenue Growth Rate 2016-2027 (US$ Million) Figure 30. United States DNA Repair Drugs Market Share in Global Market 2016-2027 Figure 31. United States 5 and 10 Largest DNA Repair Drugs Players Market Share by Revenue in DNA Repair Drugs in 2020 Figure 32. United States DNA Repair Drugs Revenue Share by Type (2016-2021) Figure 33. United States DNA Repair Drugs Revenue Growth Rate by Type in 2016 & 2020 Figure 34. United States DNA Repair Drugs Revenue Share by Application (2016-2021) Figure 35. United States DNA Repair Drugs Revenue Growth Rate by Application in 2016 & 2020 Figure 36. North America DNA Repair Drugs Sales Growth Rate 2016-2021 (K Units) Figure 37. North America DNA Repair Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 38. North America DNA Repair Drugs Sales Market Share by Country in 2020 Figure 39. North America DNA Repair Drugs Revenue Market Share by Country in 2020 Figure 40. U.S. DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 41. U.S. DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Canada DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 43. Canada DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Europe DNA Repair Drugs Sales Growth Rate 2016-2021 (K Units) Figure 45. Europe DNA Repair Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 46. Europe DNA Repair Drugs Sales Market Share by Country in 2020 Figure 47. Europe DNA Repair Drugs Revenue Market Share by Country in 2020 Figure 48. Germany DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 49. Germany DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. France DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 51. France DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. U.K. DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 53. U.K. DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. Italy DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 55. Italy DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Russia DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 57. Russia DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Asia Pacific DNA Repair Drugs Sales Growth Rate 2016-2021 (K Units) Figure 59. Asia Pacific DNA Repair Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 60. Asia Pacific DNA Repair Drugs Sales Market Share by Region in 2020 Figure 61. Asia Pacific DNA Repair Drugs Revenue Market Share by Region in 2020 Figure 62. China DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 63. China DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 64. Japan DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 65. Japan DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. South Korea DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 67. South Korea DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. India DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 69. India DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. Australia DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 71. Australia DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Taiwan DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 73. Taiwan DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Indonesia DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 75. Indonesia DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Thailand DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 77. Thailand DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Malaysia DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 79. Malaysia DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Philippines DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 81. Philippines DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Vietnam DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 83. Vietnam DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Latin America DNA Repair Drugs Sales Growth Rate 2016-2021 (K Units) Figure 85. Latin America DNA Repair Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 86. Latin America DNA Repair Drugs Sales Market Share by Country in 2020 Figure 87. Latin America DNA Repair Drugs Revenue Market Share by Country in 2020 Figure 88. Mexico DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 89. Mexico DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Brazil DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 91. Brazil DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Argentina DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 93. Argentina DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Middle East and Africa DNA Repair Drugs Sales Growth Rate 2016-2021 (K Units) Figure 95. Middle East and Africa DNA Repair Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 96. Middle East and Africa DNA Repair Drugs Sales Market Share by Country in 2020 Figure 97. Middle East and Africa DNA Repair Drugs Revenue Market Share by Country in 2020 Figure 98. Turkey DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 99. Turkey DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Saudi Arabia DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 101. Saudi Arabia DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. U.A.E DNA Repair Drugs Sales Growth Rate (2016-2021) (K Units) Figure 103. U.A.E DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. DNA Repair Drugs Value Chain Figure 105. Channels of Distribution Figure 106. Distributors Profiles Figure 107. Bottom-up and Top-down Approaches for This Report Figure 108. Data Triangulation Figure 109. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us